Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Roivant Sciences Ltd (NQ: ROIV )

7.270 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 7.270
Bid (Size) 5.710 (5)
Ask (Size) 7.940 (1)
Prev. Close 7.270
Today's Range 7.270 - 7.270
52wk Range 2.520 - 10.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share. 
Via Benzinga
Why Shares of Roivant Sciences Were Down Tuesday
After a run-up last week prompted by positive clinical trial results, the stock has given back its recent gains. 
Via The Motley Fool

Performance

YTD
+1.68%
+1.68%
1 Month
-15.17%
-15.17%
3 Month
+0.28%
+0.28%
6 Month
+128.62%
+128.62%
1 Year
+32.91%
+32.91%

More News

Read More
Analyst Expectations for Roivant Sciences's Future
Via Benzinga
Roivant Sciences Highlights Topline Data From Atopic Dermatitis Drug In Patients As Young As 2 Years
Via Benzinga
Expert Ratings for Roivant Sciences
Via Benzinga
Roivant Sciences's Earnings Outlook
Via Benzinga
Where Roivant Sciences Stands With Analysts
Via Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
Roivant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old
From Roivant Sciences
Via Globe NewsWire
Roivant to Host Investor Call at 8:00 AM ET on Wednesday, March 15 to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis
From Roivant Sciences
Via Globe NewsWire
Proteovant Therapeutics to Present Preclinical Data from Estrogen Receptor and IKZF2 Protein Degrader Programs
From Roivant Sciences
Via Globe NewsWire
Covant Therapeutics Announces the Formation of its Scientific Advisory Board to Support Platform and Pipeline Advancement
From Roivant Sciences
Via Globe NewsWire
Roivant Sciences Announces Change to its Board of Directors
From Roivant Sciences
Via Globe NewsWire
Immunovant Could Potentially Be An M&A Target, Writes Analyst
Via Benzinga
Mixed Signals On Valentine's Day: How Stocks Are Reacting To January Inflation Data
Via Benzinga
Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update
From Roivant Sciences
Via Globe NewsWire
Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares
From Roivant Sciences
Via Globe NewsWire
Earnings Scheduled For February 13, 2023
Via Benzinga
Roivant Sciences Announces Proposed Public Offering of Common Shares
From Roivant Sciences
Via Globe NewsWire
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023
From Roivant Sciences
Via Globe NewsWire
Roivant Touts Encouraging Early Data From Ulcerative Colitis Candidate
Via Benzinga
Roivant Announces Statistically Significant and Clinically Meaningful Results from the Induction Period of TUSCANY-2, a Large Global Phase 2b Study of Subcutaneous RVT-3101 for the Treatment of Ulcerative Colitis in Both the Overall and the Biomarker
From Roivant Sciences
Via Globe NewsWire
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
Via Benzinga
Why Roivant Sciences' Shares Are Up Thursday
Via The Motley Fool
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
From Roivant Sciences
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.